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Fibromyalgiasyndrome(FMS)ischaracterizedbypainreferredtodeeptissues.DiagnosisandtreatmentofFMSarecomplicatedby
avariablecoexistencewithregionalpain,fatigue,sleepdisruption,diﬃcultywithmentation,anddepression.Thewidespread,deep
pain of FMS can be a consequence of chronic psychological stress with autonomic dysregulation. Stress acts centrally to facilitate
pain and acts peripherally, via sympathetic vasoconstriction, to establish painful muscular ischemia. FMS pain, with or without a
coexistent regional pain condition, is stressful, setting up a vicious circle of reciprocal interaction. Also, stress interacts reciprocally
with systems of control over depression, mentation, and sleep, establishing FMS as a multiple-system disorder. Thus, stress and
the ischemic pain it generates are fundamental to the multiple disorders of FMS, and a therapeutic procedure that attenuates stress
and peripheral vasoconstriction should be highly beneﬁcial for FMS. Physical exercise has been shown to counteract peripheral
vasoconstriction and to attenuate stress, depression, and fatigue and improve mentation and sleep quality. Thus, exercise can
interrupt the reciprocal interactions between psychological stress and each of the multiple-system disorders of FMS. The large
literaturesupportingtheseconclusionsindicatesthatexerciseshouldbeconsideredstronglyasaﬁrst-lineapproachtoFMStherapy.
1. Mechanistic Base of FMS Prevention
and Therapy
Clinical diagnosis of ﬁbromyalgia syndrome (FMS) has
relied heavily upon tender point counts, a convenient eval-
uation of pain sensitivity that has come under scrutiny in
terms of reliability and validity [1]. Tender point testing is
designed to provide objective evidence for hypersensitivity
to palpation of deep tissues, consistent with patient reports
of ongoing pain referred to deep tissues. The location of
ongoing pain changes over time but is widespread in the
aggregate. The pain is chronic but is not always present.
These features suggest that deep tissues are chronically
sensitized and are easily brought to threshold for activation
of nociceptors. Accordingly, tests of deep pressure sensitivity
with control over the stimulus and thorough psychophysical
evaluations reveal allodynia and hyperalgesia for stimulation
of a muscle within the aggregate distribution of FMS pain.
When muscular indentations are controlled in duration
and force, FMS subjects report lower pain thresholds [2]
and substantially more pain for suprathreshold stimulation
than control subjects [2–8]. Repetitive stimulation at the
thresholdforceforpain during asingle indentation produces
higher ratings by FMS subjects, compared to repetitive
threshold stimulation for control subjects. Pain is longer in
duration for FMS subjects following a series of repetitive
muscular indentations. These observations [8] provide diag-
nostic veriﬁcation of the ongoing deep muscular pain that
brings FMS patients to the clinic.
FMS pain can arise from peripheral inﬂuences of the
autonomic nervous system [9, 10]i nr e s p o n s et oa v e r s i v e
mood states (e.g., anxiety, fear, sorrow, and depression)
that are referred to generally as mental suﬀering or dis-
tress. Distress activates the hypothalamopituitary axis (HPA)
and sympathetic nervous system to generate physiological
adaptations referred to as psychological stress reactions [11].
Stress, when chronic, results in cardiovascular dysfunction
[12–16] with reduced peripheral blood ﬂow as a result
of vasoconstriction [17–19] and reduced endothelium-
dependent vasodilatation [20, 21]. Also, chronic stress2 Pain Research and Treatment
produces mitochondrial damage and pathological changes
in the vasculature that reduce blood ﬂow [22]. Resting
levels of peripheral vasoconstriction are particularly high for
females, relative to males [23–29], and FMS primarily is a
female pain disorder [10]. Consistent with a predisposition
toward peripheral vasoconstriction, females are particularly
susceptible to Raynaud’s syndrome [30, 31], characterized by
excessive cutaneous vasoconstriction and pain in response
to ambient cold. Also, peripheral artery disease (PAD) with
reduced peripheral blood ﬂow is more prevalent for women
[32, 33]. Over time, reduced peripheral blood ﬂow can lead
to development of muscular ischemia [34, 35].
Phasic peripheral vasoconstriction, when robust, is
painful, as demonstrated by the cold pressor test. Recordings
of muscle nerve sympathetic activity (MSA) during ice water
immersion of a hand or foot have shown that pain and MSA
activity are highly correlated [36]. Similarly, acute muscular
ischemia is painful, as evidenced by the submaximal eﬀort
tourniquet test [37]. Thus, when psychological stress and
peripheral vasoconstriction become chronic and establish
muscularischemia,withsensitizationofnociceptors[38,39],
muscular pain is easily evoked [9]. In turn, nociceptive
input (e.g., from ischemic muscles) increases sympathetic
vasoconstrictor outﬂow to muscles [40, 41], reinforcing the
ischemia. Pain from vasoconstriction and muscular ischemia
can explain the referral of FMS pain to deep tissues.
In addition to ongoing or spontaneous muscular pain,
psychophysical testing of FMS individuals has revealed
widespread cutaneous hyperalgesia [42]. A parsimonious
explanation for this eﬀectis thatnociceptive input fromdeep
tissues sensitizes spinal neurons having convergent input
from the skin, resulting in cutaneous hyperalgesia within the
distribution of deep FMS pain [43]. The most thoroughly
studied form of central sensitization is temporal summation
(windup), a form of central synaptic magniﬁcation that
requires repetitive or tonic nociceptive input to central
neurons [43]. This phenomenology has led to proposals that
central sensitization underlies FMS pain [42] and also is
responsible for the widespread cutaneous hyperalgesia that
accompanies regional pain conditions [44]. However, central
sensitization from nociceptive driving does not readily
explain the widespread cutaneous hyperalgesia that accom-
panies regionally localized pain conditions [37, 45–59].
Spinal neurons supplying areas of cutaneous hypersensitivity
can be located distant from a source of regional pain. For
example, central nociceptive pathways from the foot and the
faceoriginateseparatelyfromthespinalcordandbrainstem,
with diﬀerent thalamic relays to the cerebral cortex. In spite
of this separation, temporomandibular pain is associated
with enhanced sensitivity to nociceptive stimulation of the
foot [56], and patients with irritable bowel syndrome are
hypersensitive to stimulation of the face [54]( J .R i l e y ,
A. Mauderli, and C. Vierck, unpublished observations).
Thus, a source of facilitation other than direct synaptic
driving by nociceptive input (e.g., temporal summation)
is required to generate widespread cutaneous hyperalgesia
from a regional source of pain. The stress and autonomic
dysregulation that accompany localized chronic pain can
account for widespread hyperalgesia [58, 60–66, 66–68]a n d
development of FMS pain after onset of a regional pain
condition [50].
2. Status of FMS Muscles
The relationships outlined above indicate that a primary
objective of FMS prevention and therapy should be to
reducesympatheticvasoconstrictionandmuscularischemia,
resulting in a loss or reduction of widespread deep pain
and hyperalgesia. Prevention applies to the development of
FMS in association with chronic stress (e.g., from a regional
pain condition), and reducing stress and increasing blood
supply to peripheral tissues should be therapeutic if FMS
has developed. The need to increase blood ﬂow to peripheral
tissues is strongly supported by demonstrations of muscle
pathophysiology among FMS patients. Microcirculation is
deﬁcient for FMS individuals, as indicated by reductions
in capillary density, capillary permeability, and blood ﬂow,
resulting in low tissue oxygenation [69–73]. The normal
increase in blood ﬂow during dynamic and static exercise
(hyperaemia) is attenuated for FMS subjects [74]. Intramus-
cular concentrations of pyruvate and lactate are increased for
subjectswithFMSandarenegativelycorrelatedwithpressure
pain thresholds (PPTs) for muscle [2]. Expression of genes
that detect muscle metabolites signaling pain and fatigue is
increased following exercise by FMS individuals [75]. The
strength and endurance of FMS subjects is decreased and
is associated with high ratings of exercise induced pain [76,
77]. During and following dynamic exercise, muscle tension
of FMS subjects is increased [76]. Inﬂammatory activity
is altered toward an overproduction of proinﬂammatory
cytokines [77–82]. Mitochondrial dysfunction of FMS indi-
viduals has been described, with a CoQ10 deﬁciency in blood
mononuclear cells, increased oxidative stress, and mitophagy
[83]. Thus, peripheral pathology associated with chronically
r e d u c e db l o o dﬂ o wt od e e pt i s s u e sc l e a r l yc a nb eaf a c t o ri n
generation of FMS pain.
3. ExerciseEffects on Muscles
L o n g - t e r mp r o g r a m so fe x e r c i s eh a v eb e n e ﬁ c i a le ﬀects on
stress and its eﬀects on muscles of individuals with FMS
and other conditions of ischemic muscular pain. Cardio-
vascular consequences of acute stress have been shown to
be attenuated following a bout of exercise [17, 84–88].
For individuals with hypertension, a condition associated
with chronic stress, exercise decreases sympathetic output
to muscles [89] and decreases peripheral vascular resistance
[90]. Thus, sympathetic activation by acute or chronic stress
can be attenuated by exercise. Exercise promotes angiogen-
esis and attenuates symptoms of intermittent claudication
and ischemic muscle pain associated with peripheral artery
disease [91]. Muscular contraction induces secretion of
vascular endothelial growth factor (VEGF), an essential
contributor to capillary growth in skeletal muscles [92].
Accordingly, capillary density is increased by long-term
exercise programs [93, 94]. Exercise increases expression
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oxygen consumption (VO2) is increased during exercise, to
meet increased energy needs, and it remains elevated for
hours following exercise—particularly when the exercise is
distributed in time [96]. Blood ﬂow to an exercised muscle
is increased [97–100], along with VO2 [101], with little
generalization to uninvolved muscles, avoiding hypotension
[102].Theincreaseinbloodﬂowinproportiontotherelative
activity of diﬀerent muscle groups is referred to as functional
sympatholysis, which declines with age [103]. Also following
exercise, there is generalized sympathoinhibition [104]a n d
prevention or reversal of endothelial dysfunction [105, 106].
Important functions of the endothelium that are enhanced
by exercise include vasodilation, regulation of neovascular
growth, and inﬂammatory control [105, 107].
4. TemperatureRegulation and Blood Flow
to Muscles
Control over blood ﬂow to peripheral tissues is a funda-
mental component of temperature regulation. Cold environ-
mental temperatures generate vasoconstriction, and warm
temperatures elicit vasodilation, resulting in heat retention
or loss, respectively [108]. The implications of temperature
regulationforFMSareobvious.IndividualswithFMSshould
stay warm, and exercise generates body heat. Studies of
sauna heat therapy have revealed signiﬁcant improvement
in blood ﬂow (endothelium-dependent dilation) [109–111]
and reductions in FMS pain [112, 113]. Exercise in warm
water is an eﬀective therapeutic procedure for FMS [114],
with long-term reductions in pain [115]. Exercise in water is
welltoleratedbyFMSindividuals,asitlimitsstressonweight
bearing joints and provides resistance in proportion to the
speed of movements.
5. ExerciseTherapy for Distress and Depression
In addition to widespread pain and hyperalgesia, FMS is
associated with disrupted control over numerous physiolog-
ical and psychological functions. Accordingly, there has been
a shift in emphasis away from seeing FMS strictly as a pain
disorder toward regarding it as a multisystems disorder [1,
116].SymptomsfrequentlyassociatedwithFMSpaininclude
sleep disruption, depression, fatigue, and altered mentation
(ﬁbrofog). Mechanistically, these multiple symptoms of FMS
can be seen as products of FMS pain and the stress inevitably
associated with pain. Sleep disruption, inactivity, and fatigue
are predictable consequences of chronic pain [117]a n d
stress [118–120]. Similarly, depression [118, 121, 122]a n d
memory disturbances [123, 124] can result from chronic
stress. Thus, FMS fundamentally is a disorder involving
reciprocal interactions between pain and stress. Pain can
result from or be enhanced by chronic stress [49, 66, 125–
132], and pain produces stress [64, 133–137], which has
widespread inﬂuences on biological systems [11, 62].
Mood disorders both elicit stress and are consequences
of stress. Distress, the driving force for chronic psychological
stress with HPA and sympathetic activation, is attenuated by
exerciseprogramsforindividualsrelativelyfreeofautonomic
dysregulation [138] or with hypertension [139] or chronic
pain [140, 141]. Depression, a mood disorder which often
accompanies chronic pain, including FMS, is associated
with autonomic dysregulation [142] and with cardiovascular
disease [143]. Depression can evolve from chronic stress
[121, 144, 145] and from chronic pain [146, 147], and it is
a risk factor for chronic pain [142, 148, 149]. Stress, chronic
pain and depression frequently coexist and are considered
to be reciprocally related [150], each facilitating the other.
As depression increases, so do pain complaints, and as pain
episodesincreaseinintensity, frequency,duration,orvariety,
depression becomes more likely [151]. Exercise can disrupt
these interactions by reducing pain [114, 140, 141, 152–
156] and depression [114, 140, 141, 152, 153, 156–159].
Conversely, depression occurs more frequently for sedentary
individuals [160] or when a long-term program of exercise is
interrupted for as little as 2 weeks [161].
6. Stress, Exercise,andMentation
Psychological stress can either facilitate or interfere with
learning and memory, depending upon the timing of HPA
activation relative to the event to be learned or remembered,
and the magnitude and duration of stress are critical
variables [124, 162]. While acute stress can be beneﬁcial,
chronic stress is detrimental to learning and memory.
Activation of the HPA by psychological stress prominently
involves the prefrontal cortex, amygdale, and hippocampus,
with feedback regulation via corticosteroid receptors in
these structures [123]. Chronic activation of corticosteroid
receptors within the prefrontal cortex results in neuronal
damage, impairing learning and memory [163, 164]. The
hippocampus is a component of the cerebral circuitry
mediating psychological stress and is a crucial structure for
memory consolidation. Stress reduces neurogenesis in the
hippocampus [165, 166], impairing memory and contribut-
ing to the pathophysiology of depression [167]. Depression
and cognitive decline are linked phenomena [168].
Beneﬁcial eﬀects of exercise on mentation have been
documented thoroughly [169]. Large surveys have revealed
an inverse relationship between cognitive decline (including
Alzheimer’s dementia) and levels of exercise. Prospective
studies have similarly shown an inverse relationship between
objective ﬁtness measures and cognitive decline. The largest
eﬀect sizes were for executive functions such as planning,
working memory, and multitasking. Investigations of exer-
cise programs for individuals with dementia have revealed
beneﬁcial eﬀects on cognitive tests, increased cerebral blood
ﬂow, and spared brain volume. A dose-response relationship
pertains to exercise duration/intensity and quality of life for
older individuals [170].
Laboratory animal experiments have revealed mecha-
nisms for exercise eﬀects on mentation [168]. In brief,
exercise induces a cascade of growth factor signaling that
enhances cognitive function and attenuates depression by
stimulating neuroplasticity and neurogenesis and improving
blood ﬂow. The growth factors IGF-1, BDNF, and VEGF
are increased peripherally and centrally by exercise. IGF-14 Pain Research and Treatment
increases BDNF signaling in response to exercise, enhancing
neurogenesis and synaptic plasticity in the hippocampus and
thereby facilitating learning and memory. Peripheral IGF-
1 and VEGF are necessary for exercise-induced prevention
of peripheral risk factors for cognitive decline, such as
hypertension, hyperglycemia and inﬂammation.
7. Stress, Exercise,andSleep
Psychological stress, pain, and sleep disruption are recipro-
cally related. Stress increases pain sensitivity [60, 66, 67, 171]
and disrupts sleep [120, 172]; sleep disruption results in
stress [173] with increased pain sensitivity [117, 174, 175];
pain produces stress [58, 61–64, 66, 68] and sleep disruption
[117, 175–178]. Given the beneﬁcial eﬀects of exercise on
stress and pain, reviewed above, it is not surprising that
exercise has been reported to improve sleep latency, quality,
eﬃciency, and duration and reduce next day tiredness [178–
184].
8. Methodological Considerations for
Prevention of and Therapy for FMS Pain
Ideally, a preventative/therapeutic regimen would not only
have beneﬁcial eﬀects on stress, autonomic dysregulation,
and pain but would directly or indirectly attenuate the mul-
tisystem aspects of FMS such as sleep disruption, depression,
fatigue,andﬁbrofog.Exercisehasthepotentialtoaccomplish
these goals, but it is diﬃcult to convince an FMS patient
that an acutely painful activity will reduce pain in the long
run. FMS pain can be increased during a bout of exercise
[77, 185, 186], and pain sensitivity can be increased at the
conclusion of exercise [77, 187]. Peripheral receptors that
contribute to muscular pain and fatigue [38] are expressed
and detected in leukocytes following exercise by individuals
with FMS [75]. These eﬀe c t sa r et ob ee x p e c t e dd u r i n g
and after working ischemic muscles. However, despite the
barrier of activity-induced pain, carefully structured exercise
programs can attenuate FMS pain and associated symptoms.
Gradual introduction to an exercise protocol is especially
important for FMS patients with chronic fatigue syndrome
(CFS), for whom exertion can cause postexercise malaise for
several days.
Numerous studies of exercise eﬀects on FMS symptoms
have been summarized in meta-analysis reviews that criti-
cally evaluate the experimental methods and summarize the
results. The beneﬁts of mild to moderate exercise programs
for FMS uniformly include enhanced well being, improved
physical ﬁtness, and reduced disability [140, 141]. Because
deconditioning commonly accompanies FMS [65], a strong
case can be made for exercise as a standard component
of FMS therapy. Furthermore, pain and/or tender point
counts clearly are decreased by most exercise paradigms
[114, 140, 141, 152–156]. The success rate of exercise for
pain is important, relative to therapies that rely exclusively
on pharmacological agents with side eﬀects and inherent
diﬃculties associated with long-term usage [156]. However,
individual diﬀerences in response to exercise result in a
moderateoverall(average)eﬀectonFMSpain[141,154,156,
188]. Individual variability is considerable with respect to
the severity, duration, and variety of FMS symptoms at the
inception of treatment, and the duration of chronic pain is
an important consideration. Also, the type and frequency of
exercise and long-term compliance of the subjects inﬂuence
the beneﬁts of exercise therapy.
Typical experimental protocols for aerobic exercise have
conducted supervised sessions 2 or 3 times per week [153–
155],withvaryingrecommendationsforanddocumentation
of exercise at home. Low to moderate levels of aerobic exer-
cise, as deﬁned by heart rate and blood pressure recordings,
have been recommended [152–155]. Direct comparisons
with strength training or stretching exercises have concluded
thataerobicproceduresprovidebetterresults[141,154].The
reasons for this conclusion are not clear, because assessments
of presumed mechanistic bases for FMS are not included.
For example, what are the relative eﬀects of aerobic and
strength exercises on indices of stress, autonomic regulation,
and peripheral blood ﬂow, and how are these eﬀects
related to reduction of deep muscular pain? In terms of
peripheral mechanisms of FMS such as widespread muscular
ischemia, it seems that an exercise protocol should enhance
peripheral circulation globally, rather than for a speciﬁc set
of muscles. This goal may be met by whole body aerobic
exercise or strength training of multiple muscle groups,
but documentation is needed. Also, summaries of exercise
therapy for FMS have strongly recommended tailoring of
parameters of exertion for each patient [153, 154, 156, 188].
More speciﬁcally, (1) a level of exercise which is painful for a
subject will discourage participation and may be deleterious
[188]; (2) it is important to have exercise options that are
adaptable to frequent use by individuals with diﬀerent daily
routines and/or physical limitations; (3) because chronic
stress and autonomic dysregulation are relentless, exercise
routinesarelikelytobemosteﬀectiveifconductedfrequently
so that peripheral blood ﬂow is increased over a signiﬁcant
portion of each day.
The optimal schedule of exercise likely will depend upon
the duration of increased blood ﬂow that can be expected to
accompanyandfolloweachexerciseperiod. Exercisetraining
appears not to aﬀect muscle blood ﬂow at rest [189]. Thus,
exercisetherapyforFMSisatanimportantjuncture,needing
thorough investigations of long-term eﬀects of diﬀerent
forms of exercise on blood supply to deep tissues. It is
encouraging that studies involving standardized schedules
of infrequent exercise have revealed attenuation of FMS
symptoms, but there is little to be gained by continued study
of set exercise paradigms with a ﬁxed set of parameters that
are chosen arbitrarily.
The optimum beneﬁts of exercise for FMS surely will
depend upon repeated, daily periods of exertion, but reg-
ularly scheduled laboratory sessions will be necessary to
evaluate and adjust paradigms of exercise. Tolerance for
exercise (exercise induced pain) can be assessed, both to
maximize continued participation and to measure beneﬁcial
eﬀects of exercise. If peripheral blood ﬂow is increased over
time with exercise, the threshold for exercise-induced pain
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pain following each exercise period [186], and charting the
time-course of this eﬀect in relation to changes in blood
ﬂow to deep tissues would be instructive for design and
modiﬁcation of the exercise protocol. Resting levels of blood
ﬂow to muscles, as well as changes in blood ﬂow in response
to exercise or nociceptive stimulation, are regarded here as
crucial information.
Previous studies have relied upon tender point counts
as a measure of deep pain sensitivity, but a psychophysical
test of pain during and after well-controlled compression of
s e v e r a lm u s c l eg r o u p sc a np r o v i d em o r eu s e f u li n f o r m a t i o n
on eﬀects of exercise, over time, on sensitization of noci-
ceptors in deep tissues. Psychophysical tests of sensitivity
to cutaneous stimulation (e.g., temporal summation during
repetitive stimulation) provide information on the central
sensitization that is driven by tonic nociceptive input.
Techniques for detection of biomarkers of gene expression
have been shown to be particularly informative concerning
levels of receptor expression and immune activation that
are associated with muscular fatigue and pain [75, 190].
These means for evaluation of mechanisms have provided
opportunities to approach FMS as a medical condition.
Until recently, there were questions as to whether FMS
is psychosomatic, without an identiﬁable organic basis, in
contrast to regional pain conditions with histories of injury
to the painful tissues. Ironically, the mechanistic bases of
FMS appear be identiﬁable and may also be correctable, in
contrast to many regional pain conditions without available
therapies that can silence the source of nociceptive input.
9. Summary andTherapeutic Implications
Fibromyalgia is a multiple-system disorder. FMS patients
complain of chronic pain referred to deep tissues (and
pain from exercise or palpation of muscles) and commonly
present with depression, ﬁbrofog, and sleep disruption.
FMS patients frequently are in a deconditioned state with
fatigue, and the widespread deep pain of FMS often coexists
with one or more regional pain conditions. It is not
feasible to treat each of these disorders separately (e.g.,
with pharmacological agents directed speciﬁcally to treat
each disorder). This conundrum forces consideration of
whetherthereisafundamentalmechanismforthesymptoms
that deﬁne FMS as a multiple-system disorder. Evidence
summarized here identiﬁes chronic psychological stress with
autonomicdysregulationastherootcauseofFMS,providing
opportunities for mechanism-based prevention and therapy
[191]. Pain referred to deep tissues is considered the
primary symptom of FMS. Chronic stress reduces peripheral
blood ﬂow, resulting in widespread muscular ischemia, and
muscular pain is a powerful stressor. Stress, with autonomic
dysregulation and pain, also establishes central inﬂuences
that enhance depression, impair mentation and sleep, and
increase pain. Therefore, a therapy that reduces stress and/or
pain could alleviate each of the multiple-system disorders of
FMS. Remarkably, exercise exerts beneﬁcial eﬀects on stress
and pain and the other FMS disorders. Reports documenting
these eﬀects are part of an extensive literature providing
evidence for exercise as an eﬀective therapy for many chronic
diseases of a deconditioned modern society [192].
Investigations typically report moderate overall eﬀects
of exercise on FMS symptoms, attributable to the use of
standardized exercise protocols despite considerable vari-
ability between patients. The use of ﬁxed exercise protocols
appears to suit scientiﬁc purposes but conﬂicts with a
necessity to tailor exercise to each individual for the maximal
therapeutic eﬀect. Thus, it is recommended that diﬀerent
forms, frequencies, durations, and intensities of exercise be
evaluated in terms of sustained normalization of peripheral
blood ﬂow for FMS individuals. Once an optimal pattern of
exercise is established, it can be utilized with measurements
of peripheral blood ﬂow to guide individual variations in
the exercise protocol over time. It can be expected that
eﬀective exercise protocols for pain reduction will diﬀer
between subjects and over time, as dictated by blood ﬂow to
muscles.
A mechanistic approach to FMS therapy and research
minimizestheimportanceofacontrolgroupforcomparison
with treatments such as exercise. The therapeutic goal is
to alleviate FMS, and important scientiﬁc goals are to
evaluate relationships between FMS and suspected biological
mechanisms for the FMS symptoms. At this point, these
comparisons can be more instructive than group compar-
isons with and without exercise. For evaluation of FMS pain,
it will be important to evaluate elicited ischemic pain in
addition to standard verbal reports of ongoing pain. Well-
controlled pressure stimulation of muscles with psychophys-
ical evaluation of pain threshold and the suprathreshold
intensity and duration of muscular pain is more informative
than pressure point counts. Measurements of peripheral
blood ﬂow and exercise-induced expression of biomarkers
for receptor expression and immune activation [75]a r e
informative concerning peripheral eﬀects of exercise. Assess-
ments of distress, depression, sleep quality, and mentation
provide a tracking of central eﬀects of exercise.
Correction of deconditioning with exercise is beneﬁcial
for FMS patients, but available evidence indicates that
psychological stress and peripheral vasoconstriction must be
attenuated to alleviate pain referred to deep tissues. This
paper has not covered techniques to relieve psychological
stress directly, but they can be eﬀective in combination with
exercise, attenuating reciprocal interactions with pain and
each of the multiple-system disorders of FMS.
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